|
|
Incorporated in 2006, ANG Lifesciences India Limited is a pharmaceutical company whose engaged in the business of manufactures and markets finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials in India.
Company's products include sterile dry powder vials for anti-biotics, anti-ulcerant, glucocorticoid and anti-inflammatory, anti-malarial, and anesthetic. It manufactures products in compliance with GMP requirements.
However, Company that currently operates at an average capacity utilization of 70% for last two fiscals hopes to achieve 90% plus in coming years. ANGL is likely to consider acquisition options as well to enhance its manufacturing capacities. Its customer list includes Wockhardt, DHS Maharashtra, Global Hospitals, Elder, Emcure, BPPI, Govt. of Haryana, Hetero Healthcare etc.
The promoters of the company are:
1. Rajesh Gupta
2. Saruchi Gupta
The object of the issue are:
1. To meet the working capital requirement;
2. To meet the expenses of the Issue.
| IPO Opening Date | Aug 29, 2017 |
| IPO Closing Date | Aug 31, 2017 |
| Issue Type | Fixed Price Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | ₹80 per equity share |
| Market Lot | 1600 Shares |
| Min Order Quantity | 1600 Shares |
| Listing At | BSE SME |
| Issue Size | 1,500,800 Eq Shares of ₹10 (aggregating up to ₹12.01 Cr) |
The ANG Lifesciences IPO market lot size is 1600 shares. A retail-individual investor can apply for up to 1 lots (1600 shares or ₹128,000).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 1600 | ₹128,000 |
| Maximum | 1 | 1600 | ₹128,000 |
Investors may consider investment for medium to long term in ANG Lifesciences BSE SME IPO. Read detail review...
The ANG Lifesciences IPO is subscribed times on 8/31/2017 5:00:00 PM. The public issue subscribed times in the retail category, times in the QIB category, and times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) |
|---|---|
| NII | |
| Retail | |
| Total |
| Listing Date | Friday, September 8, 2017 |
| BSE Script Code | 540694 |
| NSE Symbol | |
| Listing In | M Group of Securities |
| ISIN | INE236W01016 |
| IPO Price | ₹80 per equity share |
| Face Value | ₹10 per equity share |
|
|
ANG Lifesciences India Ltd
Darbara Complex SCO 113 I Flr,
Dist. Shopping Centre B Block,
Amritsar - 143001
Phone: +91-0183-5070118
Email: cs@anglifesciences.com
Website: http://www.anglifesciences.com
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: http://www.bigshareonline.com
ANG Lifesciences IPO is a SME IPO of 1,500,800 equity shares of the face value of ₹10 aggregating up to ₹12.01 Crores. The issue is priced at ₹80 per equity share. The minimum order quantity is 1600 Shares.
The IPO opens on Aug 29, 2017, and closes on Aug 31, 2017.
Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE SME.
The ANG Lifesciences IPO opens on Aug 29, 2017 and closes on Aug 31, 2017.
ANG Lifesciences IPO lot size is 1600 Shares and the minimum order quantity is 1600 Shares.
You can apply in ANG Lifesciences IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.
The finalization of Basis of Allotment for ANG Lifesciences IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the ANG Lifesciences IPO allotment status.
Useful Articles
IPO Guru (1900+ Posts, 1500+ Likes)
Top Contributor (300+ Posts, 200+ Likes)
